Production and sale of pharmaceutical, pesticide intermediate and other fine chemical products.

"Honesty oriented and mutural benefit cooperation"

Jiangsu Zhaoyang Chemical Co., Ltd.
Jiangsu Zhaoyang Chemical Co., Ltd.
Jiangsu Zhaoyang Chemical Co., Ltd.
Jiangsu Zhaoyang Chemical Co., Ltd.
Pharmaceutical intermediates pollution problems prominent departments need to join hands in fighting

According to the unified deployment of the Ministry of environmental protection, February 15th, the first quarter of the 2017 air quality supervision of 18 inspector groups in the first quarter of 2017 has been in the Beijing Tianjin Hebei and the surrounding areas of 18 cities. At present, the main problems found by the special supervision group of the Ministry of environmental protection include the lack of pressure transmission in Shijiazhuang, and the county government is still mainly environmental protection bureau personnel in the implementation of heavy pollution weather contingency plans, and the participation of other departments is not high. The small and medium-sized enterprises producing pharmaceutical intermediates in Shijiazhuang are seriously polluted.
The pollution problem of pharmaceutical intermediates is highlighted. All departments need to work together. Photo source: Baidu pictures.
High profit of pharmaceutical intermediates
Disordered competition in the industry is becoming increasingly fierce
The so-called pharmaceutical intermediates are actually some chemical raw materials or chemical products used in the process of pharmaceutical synthesis. This chemical product, which does not require a production license of a drug, can be produced in a common chemical plant and can be used for the synthesis of drugs as long as it reaches some level.
It is understood that after years of development, China's pharmaceutical production needs of chemical raw materials and intermediates can be matched basically, only a small part of the need to import. Moreover, because of the abundant resources and low price of raw materials, many intermediates have exported a lot.
Throughout the industry, China's pharmaceutical intermediates are mostly private enterprises, with flexible management and small investment. As the country pays more attention to environmental protection problems, the pressure on the construction of environmental treatment facilities is increasing, which compels enterprises to continuously develop new products or continuously improve production processes. Hold high production profit.
Furthermore, as the production profit of pharmaceutical intermediates is higher than that of chemical products, the production process of both of them is basically the same, so more and more small chemical enterprises have joined the ranks of pharmaceutical intermediates, which leads to the increasingly fierce competition in the industry. In the face of interests, many manufacturers bury "green", which also causes a lot of industrial pollution.
In front of environmental pressure
All departments need to fight hand in hand
According to Xue Xinli, director of the Tianjin Municipal Development and Reform Commission, it is the current goal to strengthen the coordination of three air pollution control, implement unified implementation of regional heavy pollution weather warning standards, strengthen the linkage of environmental enforcement and emergency disposal, jointly carry out environmental law enforcement supervision and inspection, and investigate and deal with transboundary environmental violations.
The relevant departments should fully cooperate with the progress of pollution control. As a part of the pollution source, the medium and small enterprises of pharmaceutical intermediates should also fully cooperate with environmental law enforcement departments to pay attention to the pollution problem and put down the immediate interests to take the road of sustainable development.
Pharmaceutical industry is not only a high-risk, high-investment, high-tech, high-return industry, but also China's environmental protection, energy conservation and emission reduction task is very heavy industry. Since twenty-first Century, China's pharmaceutical industry has maintained a rapid development speed. In the face of environmental pressure, medical enterprises need to improve environmental technology, follow the concept of green production, instead of blindly making production and evading the principle of environmental protection.
Summary:
Overall, China's pollution control task is still very arduous, small scattered pollution enterprises exist in varying degrees, the "hard bones" will not be reduced. At the same time, we should also see that the pollution problem is not formed in a short period of time, can not be solved overnight, overnight, overnight, need a longer process. From the current situation, all sectors of our country must work hand in hand, be solid, step by step, and work for a long time. As long as we stick to promoting the work of air pollution prevention and control, we will get out of fog and haze one day.
(source: China Pharmaceutical network)

Copyright(C)2018,  Jiangsu Zhaoyang Chemical Co., Ltd.  All Rights Reserved.  Supported by  ChinaChemNet  ChemNet  Toocle  Copyright Notice  备案序号:苏ICP备12061493号